Pharmacological inhibition of Glycogen Synthase Kinase 3 increases operant alcohol self-administration in a manner associated with altered pGSK-3β, PICK1 and GluA2 protein expression in the reward pathway of male C57BL/6J mice

Glycogen synthase kinase 3 (GSK-3) is a constitutively active serine-threonine kinase that regulates numerous signaling pathways and has been implicated in neurodegenerative and neuropsychiatric diseases including Alzheimer’s, Parkinson’s, schizophrenia, and bipolar disorder. Evidence indicates that...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Behav Pharmacol
Main Authors: Faccidomo, Sara, Holstein, Sarah E, Santanam, Taruni S, Saunders, Briana L., Swaim, Katarina S., Reid, Grant T, O’Neill, Conor, Eastman, Vallari R, Hodge, Clyde W
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6954298/
https://ncbi.nlm.nih.gov/pubmed/31503067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FBP.0000000000000501
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados